Disc Medicine, Inc. — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-03-01

Reporting Person: Strapps Walter (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Stock Option (Right to Buy)	$15.60	A	99133	Acquired	2031-02-28	Common Stock (99133)	Direct

Footnotes

F1: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 1, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.